Search
for

    Sort by

    Research 211–240 of 648

    1. Endocrinology Clinical Chemistry and Laboratory Medicine · 2023
    2. 5-alpha reductase inhibitors use in prostatic disease and beyond Translational Andrology and Urology · 2023
    3. Benefits of Testosterone Replacement and Methods of Substitution IntechOpen eBooks · 2023
    4. A systematic review on Drug Re-profiling/Re-Purposing IARS international research journal · 2022
    5. Triple Hormonal Blockade (ADT3): A Patient’s Perspective Oncogen · 2019
    6. The Interplay between Finasteride-Induced Androgen Imbalance, Endoplasmic Reticulum Stress, Oxidative Stress, and Liver Disorders in Paternal and Filial Generation Biomedicines · 2022
    7. Comorbidities in Androgenetic Alopecia: A Comprehensive Review Dermatology and therapy · 2022
    8. Finasteride Drugs · 1999 · 125 citations
    9. Revolutionizing psoriasis care: Microneedle innovations in treatment and diagnosis Nano Research · 2025
    10. Effect of finasteride and/or terazosin on serum PSA: Results of VA cooperative study #359 The Prostate · 1999 · 41 citations
    11. Antiandrogen Drugs Lower Serum Prostate-Specific Antigen (PSA) Levels in Hirsute Subjects: Evidence That Serum PSA Is a Marker of Androgen Action in Women<sup>1</sup> 2000 · 16 citations
    12. Prostate specific antigen (PSA) in diagnosis of polycystic ovarian syndrome – a new insight Gynecological Endocrinology · 2016 · 6 citations
    13. What are the possible reasons for urethral PSA varieties after radical prostatectomy? Acta Chirurgica Iugoslavica · 2010 · 5 citations
    14. Effect of finasteride and/or terazosin on serum PSA: Results of VA cooperative study #359 The Prostate · 1999 · 3 citations
    15. Efficacy of <i>Serenoa repens</i> lipido-sterolic extract alone or in combination with propolis polyphenols and <i>Boswellia serrata</i> extract suppositories on PSA level and symptoms in patients affected by lower urinary tract disorders Archivio Italiano di Urologia e Andrologia · 2025 · 1 citations
    16. Phase I-II trial of weekly bicalutamide in men with high PSA and negative biopsy Journal of Clinical Oncology · 2007 · 1 citations
    17. PSA Test Sensitized by Finasteride Oncology times · 2006 · 1 citations
    18. 5ARI and PSA: open questions Urologia Journal · 2014
    19. 1262 ONE YEAR FINASTERIDE THERAPY IN MEN WITH A SERUM PSA GREATER THAN 4 NG/ML WHO HAD UNDERGONE REPEAT BIOPSY The Journal of Urology · 2012
    20. S2 PSA: RELIABLE OR NOT RELIABLE? European Urology Supplements · 2010
    21. S90 Urethral PSA production after radical prostatectomy European Urology Supplements · 2009
    22. IMPACT OF LOW DOSE FINASTERIDE FOR THE TREATMENT OF ANDROGENIC ALOPECIA ON SERUM PROSTATE SPECIFIC ANTIGEN (PSA) LEVELS IN MEN PARTICIPATED IN POPULATION-BASED SCREENING FOR PROSTATE CANCER The Journal of Urology · 2009
    23. Association between PSA and leptin, adiponectin, HbA1c, or C-peptide among African-American and Caucasian men Cancer Epidemiology and Prevention Biomarkers · 2007
    24. Are PSA adjustments necessary for prostate cancer screening in men taking finasteride for hair loss? Nature Clinical Practice Urology · 2007
    25. Finasteride reduces serum PSA to a similar extent at 1 mg and 5 mg daily doses Nature Clinical Practice Urology · 2007
    26. Effect of Low-Dose Finasteride on Serum PSA Concentrations Journal watch · 2007
    27. Impact of baseline PSA level on quality of life measures of general health and sexual satisfaction/drive in men with BPH treated with finasteride or placebo European Urology Supplements · 2003
    28. PD16-01 NEW INSIGHT OF PSA REDUCTION DURING FINASTERIDE THERAPY The Journal of Urology · 2015
    29. PSA concentration change in men taking low dose finasteride and dutasteride for male androgenetic alopecia ics.org · 2017
    30. The Percentage of Free PSA and Urinary Markers Distinguish Prostate Cancer from Benign Hyperplasia and Contribute to a More Accurate Indication for Prostate Biopsy Biomedicines · 2020 · 11 citations